All News #Library
Rare Diseases
Deciphera Gets EU Approval for Romvimza to Treat TGCT Tumor
17 Sep 2025 //
PHARMAWEB
FDA approves Ono`s rare tumor drug from $2.4B Deciphera buyout
15 Feb 2025 //
FDA

Market Place
Sourcing Support